Second, the trial was stopped early for efficacy, and there could be a risk of inflated estimates of differences between the intervention and standard of care, although this risk is presumably small as we found highly significant differences.
← all excerpts
Diagnostic Stewardship in Community-Acquired Pneumonia With Syndromic Molecular Testing: A Randomized Clinical Trial.
1
—
—